The chemokine GRO-α (CXCL1) confers increased tumorigenicity to glioma cells

Carcinogenesis

Volumn 26, Issue 12, 2005, Pages 2058-2068

  Zhou, Yan ^a   Zhang, Jing ^a   Liu, Qiang ^b   Bell, Robert ^a   Muruve, Daniel A ^b   Forsyth, Peter ^a   Arcellana Panlilio, Mayi ^b   Robbins, Stephen ^a,b   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CHEMOKINE; CXCL1 CHEMOKINE; GELATINASE A; OSTEONECTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN TUMOR; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIA CELL; GLIOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR CELL CULTURE;

ANIMALS; ANTIGENS, CD29; ASTROCYTOMA; BRAIN NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CHEMOKINES, CXC; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 27944486755     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi182     Document Type: Article

References (60)

1. Holland,E.C. (2000) Glioblastoma multiforme: The terminator. Proc. Natl Acad. Sci. USA, 97, 6242-6244.
2. Scott,J.N., Rewcastle,N.B., Brasher,P.M., Fulton,D., MacKinnon,J.A., Hamilton,M., Cairncross,J.G. and Forsyth,P. (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann. Neurol., 46, 183-188.
3. Giese,A. and Westphal,M. (2001) Treatment of malignant glioma: A problem beyond the margins of resection. J. Cancer Res. Clin. Oncol., 127, 217-225.
4. Besson,A. and Yong,V.W. (2001) Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J. Neurooncol., 51, 245-264.
5. Wild-Bode,C., Weller,M. and Wick,W. (2001) Molecular determinants of glioma cell migration and invasion. J. Neurosurg., 94, 978-984.
6. Le,D.M., Besson,A., Fogg,D.K., Choi,K.S., Waisman,D.M., Goodyer,C.G., Rewcastle,B. and Yong,V.W. (2003) Exploitation of astrocytes by glioma cells to facilitate invasiveness: A mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J. Neurosci., 23, 4034-4043.
7. Proudfoot,A.E. (2002) Chemokine receptors: Multifaceted therapeutic targets. Nat. Rev. Immunol., 2, 106-115.
8. Balkwill,F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer, 4, 540-550.
9. Muller,A., Homey,B., Soto,H. et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
10. Richmond,A. (2002) Nf-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol., 2, 664-674.
11. Payne,A.S. and Cornelius,L.A. (2002) The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol., 118, 915-922.
12. Yoshimura,T. and Kuratsu,J. (1999) Chemokines and central nervous system malignancies. In B.J. Rollins (ed.) Chemokines and Cancer. Humana Press, Totowa, pp. 227-241.
13. Oh,J.W., Schwiebert,L.M. and Benveniste,E.N. (1999) Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J. Neurovirol., 5, 82-94.
14. Desbaillets,I., Diserens,A.C., Tribolet,N., Hamou,M.F. and Van Meir,E.G. (1997) Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med., 186, 1201-1212.
15. Noe,K.H., Cenciarelli,C., Moyer,S.A., Rota,P.A. and Shin,M.L. (1999) Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J. Virol., 73, 3117-3124.
16. Rempel,S.A., Dudas,S., Ge,S. and Gutierrez,J.A. (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin. Cancer Res., 6, 102-111.
17. Salmaggi,A., Gelati,M., Pollo,B. et al. (2004) CXCL12 in malignant glial tumors: A possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J. Neurooncol., 67, 305-317.
18. Zhou,Y., Larsen,P.H., Hao,C. and Yong,V.W. (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem., 277, 49481-49487.
19. Moore,B.B., Arenberg,D.A., Stoy,K. et al. (1999) Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol., 154, 1503-1512.
20. Dhawan,P. and Richmond,A. (2002) Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol., 72, 9-18.
21. Robinson,S., Tani,M., Strieter,R.M., Ransohoff,R.M. and Miller,R.H. (1998) The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci., 18, 10457-10463.
22. Wu,Q., Miller,R.H., Ransohoff,R.M., Robinson,S., Bu,J. and Nishiyama,A. (2000) Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J. Neurosci., 20, 2609-2617.
23. Tsai,H.H., Frost,E., To,V., Robinson,S., Ffrench-Constant,C., Geertman,R., Ransohoff,R.M. and Miller,R.H. (2002) The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell, 110, 373-383.
24. Robinson,S., Cohen,M., Prayson,R., Ransohoff,R.M., Tabrizi,N. and Miller,R.H. (2001) Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas. Neurosurgery, 48, 864-873; discussion 873-874.
25. Besson,A., Wilson,T.L. and Yong,V.W. (2002) The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. J. Biol. Chem., 277, 22073-22084.
26. Ishii,N., Maier,D., Merlo,A., Tada,M., Sawamura,Y., Diserens,A.C. and Van Meir,E.G. (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol., 9, 469-479.
27. Besson,A., Davy,A., Robbins,S.M. and Yong,V.W. (2001) Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene, 20, 7398-7407.
28. Uhm,J.H., Dooley,N.P., Villemure,J.G. and Yong,V.W. (1996) Glioma invasion in vitro: Regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metastasis, 14, 421-433.
29. Yang,Y.H., Dudoit,S., Luu,P., Lin,D.M., Peng,V., Ngai,J. and Speed,T.P. (2002) Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res., 30, e15.
30. Lamszus,K., Laterra,J., Westphal,M. and Rosen,E.M. (1999) Scatter factor/ hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int. J. Dev. Neurosci., 17, 517-530.
31. Plow,E.F., Haas,T.A., Zhang,L., Loftus,J. and Smith,J.W. (2000) Ligand binding to integrins. J. Biol. Chem., 275, 21785-21788.
32. Yamamoto,M., Mohanam,S., Sawaya,R., Fuller,G.N., Seiki,M., Sato,H., Gokaslan,Z.L., Liotta,L.A., Nicolson,G.L. and Rao,J.S. (1996) Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56, 384-392.
33. Forsyth,P., Lafleur,M., Edwards,D., Yong,V.W.(2001) Proteases and their inhibitors in gliomas. In Lajtha,A. and Banik, N.L. (eds). Role of Proteases in the Pathophysiology of Neurodegenerative Diseases. Kluwer Academic/Plenum, New York, pp. 241-268.
34. Pagenstecher,A., Wussler,E.M., Opdenakker,G., Volk,B. and Campbell,I.L. (2001) Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors. J. Neuropathol. Exp. Neurol., 60, 598-612.
35. Huang,H., Colella,S., Kurrer,M., Yonekawa,Y., Kleihues,P. and Ohgaki,H. (2000) Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res., 60, 6868-6874.
36. Rempel,S.A., Golembieski,W.A., Ge,S., Lemke,N., Elisevich,K., Mikkelsen,T. and Gutierrez,J.A. (1998) SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J. Neuropathol. Exp. Neurol., 57, 1112-1121.
37. Schultz,C., Lemke,N., Ge,S., Golembieski,W.A. and Rempel,S.A. (2002) Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res., 62, 6270-6277.
38. Feldkamp,M.M., Lau,N. and Guha,A. (1997) Signal transduction pathways and their relevance in human astrocytomas. J. Neurooncol., 35, 223-248.
39. Nagane,M., Lin,H., Cavenee,W.K. and Huang,H.J. (2001) Aberrant receptor signaling in human malignant gliomas: Mechanisms and therapeutic implications. Cancer Lett., 162 Suppl, S17-S21.
40. Holland,E.C., Celestino,J., Dai,C., Schaefer,L., Sawaya,R.E. and Fuller,G.N. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet., 25, 55-57.
41. Holland,E.C. (2001) Progenitor cells and glioma formation. Curr. Opin. Neurol., 14, 683-688.
42. Strieter,R.M., Polverini,P.J., Kunkel,S.L., Arenberg,D.A., Burdick,M.D., Kasper,J., Dzuiba,J., Van Damme,J., Walz,A. and Marriott,D. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem., 270, 27348-27357.
43. Belperio,J.A., Keane,M.P., Arenberg,D.A., Addison,C.L., Ehlert,J.E., Burdick,M.D. and Strieter,R.M. (2000) CXC chemokines in angiogenesis. J. Leukoc. Biol., 68, 1-8.
44. Mackay,C.R. (2001) Chemokines: Immunology's high impact factors. Nat. Immunol., 2, 95-101.
45. Homey,B., Muller,A. and Zlotnik,A. (2002) Chemokines: Agents for the immunotherapy of cancer? Nat. Rev. Immunol., 2, 175-184.
46. Platten,M., Kretz,A., Naumann,U., Aulwurm,S., Egashira,K., Isenmann,S. and Weller,M. (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann. Neurol., 54, 388-392.
47. Paulus,W. and Tonn,J.C. (1994) Basement membrane invasion of glioma cells mediated by integrin receptors. J. Neurosurg., 80, 515-519.
48. Bradshaw,A.D. and Sage,E.H. (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest., 107, 1049-1054.
49. Menon,P.M., Gutierrez,J.A. and Rempel,S.A. (2000) A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin. Int. J. Oncol., 17, 683-693.
50. Rempel,S.A., Golembieski,W.A., Fisher,J.L., Maile,M. and Nakeff,A. (2001) SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J. Neurooncol., 53, 149-160.
51. Rutka,J.T., Ivanchuk,S., Mondal,S., Taylor,M., Sakai,K., Dirks,P., Jun,P., Jung,S., Becker,L.E. and Ackerley,C. (1999) Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int. J. Dev. Neurosci., 17, 503-515.
52. Rutka,J.T. and Smith,S.L. (1993) Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity. Cancer Res., 53, 3624-3631.
53. Rutka,J.T., Ackerley,C., Hubbard,S.L., Tilup,A., Dirks,P.B., Jung,S., Ivanchuk,S., Kurimoto,M., Tsugu,A. and Becker,L.E. (1998) Characterization of glial filament-cytoskeletal interactions in human astrocytomas: An immuno-ultrastructural analysis. Eur. J. Cell Biol., 76, 279-287.
54. Hirano,H., Lopes,M.B., Laws,E.R., Jr., Asakura,T., Goto,M., Carpenter,J.E., Karns,L.R. and VandenBerg,S.R. (1999) Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro-oncol., 1, 109-119.
55. Wang,H., Wang,H., Shen,W., Huang,H., Hu,L., Ramdas,L., Zhou,Y.H., Liao,W.S., Fuller,G.N. and Zhang,W. (2003) Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res., 63, 4315-4321.
56. Arese,M., Chen,Y., Florkiewicz,R.Z., Gualandris,A., Shen,B. and Rifkin,D.B. (1999) Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol. Biol. Cell, 10, 1429-1444.
57. Soulet,F., Al Saati,T., Roga,S., Amalric,F. and Bouche,G. (2001) Fibroblast growth factor-2 interacts with free ribosomal protein S19. Biochem. Biophys. Res. Commun., 289, 591-596.
58. Peng,H., Myers,J., Fang,X., Stachowiak,E.K., Maher,P.A., Martins,G.G., Popescu,G., Berezney,R. and Stachowiak,M.K. (2002) Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J. Neurochem., 81, 506-524.
59. Liotta,L.A. and Kohn,E.C. (2001) The micro-environment of the tumour-host interface. Nature, 411, 375-379.
60. Coussens,L.M. and Werb,Z. (2002) Inflammation and cancer. Nature, 420, 860-867.